Elysium Creatine+: A Three-Ingredient Stack Targeting Strength, Recovery, and Longevity
Elysium Health's new Creatine+ combines creatine monohydrate with HMB and pomegranate-derived urolithin A precursors — a longevity-focused formulation co-developed with a Stanford longevity researcher.
Sky Labs' CART BP Pro Ring Heads to Europe After 260K+ South Korean Prescriptions
Sky Labs is launching its cuffless blood pressure monitoring ring in Europe and the UK, backed by CE-MDR certification and a 260,000+ prescription track record in South Korea.
Geroscience Is Rewriting the Logic of Disease Prevention
Thirty percent of centenarians escape major age-related disease entirely — not by treating conditions as they arrive, but by aging differently. Geroscience targets the shared biological mechanisms underlying multiple diseases simultaneously. Here's where the clinical evidence stands in 2026.
The Breast Cancer Screening Framework Peter Attia Uses — And Why Standard Mammogram Advice Falls Short
Risk-stratified screening starts with a formal risk assessment by age 25 — not when your doctor first orders a mammogram at 40. Peter Attia's framework explains why, and what the implementation failure actually looks like at scale.
The World's First Human Kidney Regeneration Surgery Is Scheduled for July 2026
Rokit Healthcare has clinical approval to begin the first human kidney regeneration trial using AI-assisted 3D bioprinting and robotic surgery with the patient's own omentum-derived cells — a milestone that sidesteps transplant waiting lists entirely.
China Launches the World's First 2,000-Person Stem Cell Antiaging Trial
Beijing's 301 Hospital is running the largest stem cell trial ever attempted for aging prevention, shifting longevity science from disease treatment toward systemic intervention.
Immorta Bio's Combination Therapy Reports 70%+ Lifespan Extension in Animal Models
A peer-reviewed study combining senolytic immunotherapy with stem cell regeneration shows dramatic lifespan gains. What the animal data does and doesn't tell us.
Evipedia: 500+ Longevity Interventions, One Evidence Standard
The Forever Healthy Foundation's Evipedia organizes longevity science across 500+ interventions using AI-assisted audit-based reviews — a practical research tool for practitioners navigating the evidence problem.
Longevity Tourism: A Practical Guide to Health Destination Travel in 2026
From $899 MRI screenings to $85K concierge memberships — a framework for evaluating longevity travel destinations, what each protocol tier actually delivers, and how to calibrate spend against evidence quality.
Biological Optionality: Why Freezing Your Younger Cells Now Is a Bet on Future Medicine
Acorn Biolabs harvests mesenchymal stem cells from hair follicles and cryopreserves them—banking the secretome of a healthier version of you against therapies that don't exist yet.
Alamar's Dried Blood Spot Kit Makes Hospital-Grade Proteomics Work on a Fingerstick at Home
Alamar Biosciences' NULISA DBS Extraction Kit extends proximity ligation proteomics to dried blood spot samples—85–95% detectability, compatible with Capitainer and Mitra devices, ships standard mail.
VERVE-102 and the Beginning of the End of Atherosclerosis
A Phase I trial published in the New England Journal of Medicine shows VERVE-102, a one-time base-editing gene therapy, can cut PCSK9 protein levels by up to 88% and LDL cholesterol by up to 62% — potentially permanently — in high-risk cardiovascular patients.
InsideTracker Pivots to AI Platform: What the Terra Shift Means for Biohacking
InsideTracker is becoming Terra, a B2B AI platform licensing biomarker-based health guidance to wellness and healthcare companies. The consumer brand isn't gone — it's becoming infrastructure.
Oura Ring 5: The Smallest Smart Ring Gets Serious About Health Data
Oura Ring 5 launches 40% smaller with a month-long charging case, blood pressure signal detection, and GLP-1 medication insights. What's genuinely new and who the upgrade makes sense for.
Plasma Exchange Cuts Blood Microplastics by 60%: First Clinical Data
A May 2026 study in the Journal of Clinical Apheresis found therapeutic plasma exchange reduced blood microplastic levels from 52.2 to 21.1 particles per 100µL — the first peer-reviewed data on clinically removing microplastics from circulation.
Elysium Health Launches Physician-Led Longevity Program — Moving From Supplements to Clinical Care
Elysium's new Elysium Longevity Institute combines NAD+ protocols, peptides, and longitudinal data tracking under physician oversight. The shift signals a broader move in longevity from consumer supplementation to integrated clinical programs.
Oura Ring 5: The World's Smallest Smart Ring Adds Blood Pressure Signals and GLP-1 Insights
Oura Ring 5 launches 40% smaller than its predecessor with rebuilt sensors, blood pressure monitoring signals, and a portable charging case. Here's what's new and who the upgrade makes sense for.
Sleep Pharmacology: Why Most Sleep Drugs Don't Deliver What You Think
Peter Attia's Episode 394 tackles which sleep medications actually work and which only sedate. The core insight — sedation is not sleep — reframes how to think about every drug in this category.
77% of Max Strength Gains With Light Weights Twice a Week
A meta-analysis of 192 studies finds that light-load, multi-set training twice a week captures 77% of maximal strength gains. The gap between optimal and accessible is far smaller than the fitness industry suggests.
resbiotic Makes Shotgun Metagenomics an At-Home Gut Test
resbiotic's at-home gut health test uses shotgun metagenomic sequencing — the same method clinical researchers use — with HSA/FSA eligibility and a 60-90 day retesting cadence built around lifestyle optimization.
Battery-Free Brain Implant Leaves the Lab: ABILITY Neurotech's ALS Trial
ABILITY Neurotech's optical-link BCI received approval for chronic home use in ALS patients — the first time this class of device moves from controlled demonstrations to real-world daily use.
Wearables: When Your Fitness Tracker Becomes a Medical Device
WHOOP's 2025 FDA warning revealed a hidden boundary inside wearables. As brands add clinical features, the wellness exemption is under pressure — and the implications run far beyond WHOOP.
Growth Hormone for Injury Recovery: The Evidence Gap Between Clinics and Clinical Trials
hGH reliably raises IGF-1. IGF-1 drives anabolic signaling. Somewhere between that mechanism and the recovery outcomes being sold in wellness clinics, the evidence breaks down.
Wearables Are Writing Checks the FDA Can't Cash: The Regulatory Gap Getting Harder to Ignore
WHOOP earned $34.5M in federal backing. Apple Watch won an ECG clearance. And the FDA's framework for governing what these devices claim is still built for episodic care, not continuous monitoring.